Crystallization (Comment) | Organism |
---|---|
sitting drop vapor diffusion method, crystal structures of type II dehydroquinase with the inhibitors 2,3-anhydroquinate, citrate or N-tetrazol-5-yl-9-oxo-9H-xanthene-2-sulfonamide | Helicobacter pylori |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2,3-anhydroquinate | - |
Helicobacter pylori | |
citrate | - |
Helicobacter pylori | |
N-tetrazol-5-yl-9-oxo-9H-xanthene-2-sulfonamide | - |
Helicobacter pylori |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Helicobacter pylori | Q48255 | - |
- |
Synonyms | Comment | Organism |
---|---|---|
Type II dehydroquinase | - |
Helicobacter pylori |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0025 | - |
citrate | - |
Helicobacter pylori | |
0.02 | - |
N-tetrazol-5-yl-9-oxo-9H-xanthene-2-sulfonamide | - |
Helicobacter pylori | |
0.37 | - |
2,3-anhydroquinate | - |
Helicobacter pylori |